{"id":137,"date":"2015-01-01T01:27:00","date_gmt":"2015-01-01T01:27:00","guid":{"rendered":"https:\/\/cfedsc.org\/?p=137"},"modified":"2023-03-23T14:40:00","modified_gmt":"2023-03-23T14:40:00","slug":"the-concomitant-use-of-1-aminoglycoside-antibiotics-gentamicin-amikacin-and-tobramycin-and-2-kalydeco-vx-770-in-f508del-g542x-heterozygous-individuals-with-cystic-fibrosis-may-increase","status":"publish","type":"post","link":"https:\/\/cfedsc.org\/?p=137","title":{"rendered":"The Concomitant Use of (1) Aminoglycoside Antibiotics (Gentamicin, Amikacin and Tobramycin) and (2) Kalydeco\u00ae (VX-770) in F508del\/G542X Heterozygous Individuals with Cystic Fibrosis May Increase Readthrough of the G542X Premature Stop Codon and Potentiate the Functional G542X Containing CFTR Protein at the Apical Cell Membrane"},"content":{"rendered":"\n<h1 class=\"wp-block-heading\">The Concomitant Use of (1) Aminoglycoside Antibiotics (Gentamicin, Amikacin and Tobramycin) and (2) Kalydeco\u00ae (VX-770) in F508del\/G542X Heterozygous Individuals with Cystic Fibrosis May Increase Readthrough of the G542X Premature Stop Codon and Potentiate the Functional G542X Containing CFTR Protein at the Apical Cell Membrane<\/h1>\n","protected":false},"excerpt":{"rendered":"<p>The Concomitant Use of (1) Aminoglycoside Antibiotics (Gentamicin, Amikacin and Tobramycin) and (2) Kalydeco\u00ae (VX-770) in F508del\/G542X Heterozygous Individuals with Cystic Fibrosis May Increase Readthrough of the G542X Premature Stop Codon and Potentiate the Functional G542X Containing CFTR Protein at the Apical Cell Membrane<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[10],"class_list":["post-137","post","type-post","status-publish","format-standard","hentry","category-abstracts","tag-abstracts"],"_links":{"self":[{"href":"https:\/\/cfedsc.org\/index.php?rest_route=\/wp\/v2\/posts\/137","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cfedsc.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cfedsc.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cfedsc.org\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/cfedsc.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=137"}],"version-history":[{"count":0,"href":"https:\/\/cfedsc.org\/index.php?rest_route=\/wp\/v2\/posts\/137\/revisions"}],"wp:attachment":[{"href":"https:\/\/cfedsc.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=137"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cfedsc.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=137"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cfedsc.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=137"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}